Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06696716 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

ONO-4059 Study in Patients With Steroid-resistant Pemphigus

StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status changed: Recruiting → Active, Not Recruiting Site details revised at 25 of 25 sitesv8 Show 1 more changeShow less
    • Site details revised at 25 of 25 sites
  2. Changed Sponsor changed: Ono Pharmaceutical Co. Ltd to Ono Pharmaceutical Co., Ltd.
  3. Site details revised at 3 of 25 sitesv7
  4. Study sites: 20 to 25v6
  5. Re-verified, no change to tracked fieldsv5
Show 3 earlier versionsHide 3 earlier versions
  1. Site details revised at 5 of 20 sitesv4
  2. Site details revised at 13 of 20 sitesv3
  3. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
ONO-4059-10:Multicenter, placebo-controlled, randomized, double-blind, Phase 3 study in patients with steroid-resistant pemphigus
Trial Details
NCT Number NCT06696716
Lead Sponsor Ono Pharmaceutical Co., Ltd.
Conditions Pemphigus, Steroid-resistant Pemphigus
Enrollment 34 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov